Gender Disparities in Statins Prescriptions in People with HIV with Low/moderate to High Cardiovascular Risk

Irene A Abela,Frédérique Chammartin,Alain Amstutz,Bernard Surial,Marie Ballif,Catia Marzolini,Karoline Aebi-Popp,Julia Notter,Olivier Segeral,Marcel Stoeckle,Matthias Cavassini,Enos Bernasconi,Huldrych F Günthard,Roger D Kouyos,Chloé Pasin,Swiss HIV Cohort Study

Open forum infectious diseases（2024）

引用 0|浏览8

暂无评分

摘要

Abstract The REPRIEVE trial suggests that primary CVD prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statins-based CVD prevention.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要